Ocugen, Inc. (OCGN)
1.37
-0.04
(-2.84%)
USD |
NASDAQ |
Aug 27, 16:00
1.37
0.00 (0.00%)
After-Hours: 20:00
Ocugen Max Drawdown (5Y) : 99.77% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 99.77% |
| June 30, 2026 | 99.77% |
| May 31, 2026 | 99.77% |
| April 30, 2026 | 99.77% |
| March 31, 2026 | 99.77% |
| February 28, 2026 | 99.77% |
| January 31, 2026 | 99.77% |
| December 31, 2025 | 99.77% |
| November 30, 2025 | 99.88% |
| October 31, 2025 | 99.90% |
| September 30, 2025 | 99.90% |
| August 31, 2025 | 99.92% |
| July 31, 2025 | 99.92% |
| June 30, 2025 | 99.95% |
| May 31, 2025 | 99.95% |
| April 30, 2025 | 99.95% |
| March 31, 2025 | 99.95% |
| February 28, 2025 | 99.96% |
| January 31, 2025 | 99.96% |
| December 31, 2024 | 99.96% |
| November 30, 2024 | 99.96% |
| October 31, 2024 | 99.96% |
| September 30, 2024 | 99.96% |
| August 31, 2024 | 99.96% |
| July 31, 2024 | 99.96% |
| Date | Value |
|---|---|
| June 30, 2024 | 99.96% |
| May 31, 2024 | 99.96% |
| April 30, 2024 | 99.96% |
| March 31, 2024 | 99.96% |
| February 29, 2024 | 99.96% |
| January 31, 2024 | 99.96% |
| December 31, 2023 | 99.96% |
| November 30, 2023 | 99.96% |
| October 31, 2023 | 99.96% |
| September 30, 2023 | 99.96% |
| August 31, 2023 | 99.96% |
| July 31, 2023 | 99.96% |
| June 30, 2023 | 99.96% |
| May 31, 2023 | 99.96% |
| April 30, 2023 | 99.96% |
| March 31, 2023 | 99.96% |
| February 28, 2023 | 99.96% |
| January 31, 2023 | 99.96% |
| December 31, 2022 | 99.96% |
| November 30, 2022 | 99.96% |
| October 31, 2022 | 99.96% |
| September 30, 2022 | 99.96% |
| August 31, 2022 | 99.96% |
| July 31, 2022 | 99.96% |
| June 30, 2022 | 99.96% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| CytomX Therapeutics, Inc. | 97.05% |
| ACADIA Pharmaceuticals, Inc. | 77.18% |
| Biogen, Inc. | 72.66% |
| Gilead Sciences, Inc. | 26.58% |
| MannKind Corp. | 69.35% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -52.80 |
| Beta (5Y) | 2.213 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 89.28% |
| Historical Sharpe Ratio (5Y) | -0.3632 |
| Historical Sortino (5Y) | -0.8972 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 31.50% |